These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7957527)

  • 1. Pharmacokinetics of ganciclovir in a patient undergoing chronic haemodialysis.
    Combarnous F; Fouque D; Bernard N; Boulieu R; Chossegros P; Laville M; Zech P
    Eur J Clin Pharmacol; 1994; 46(4):379-81. PubMed ID: 7957527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ganciclovir in a patient undergoing hemodialysis.
    Swan SK; Munar MY; Wigger MA; Bennett WM
    Am J Kidney Dis; 1991 Jan; 17(1):69-72. PubMed ID: 1846060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous hemodialysis.
    Boulieu R; Bastien O; Bleyzac N
    Ther Drug Monit; 1993 Apr; 15(2):105-7. PubMed ID: 8389067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of ganciclovir during renal failure and continuous hemodialysis.
    Bastien O; Boulieu R; Bleyzac N; Estanove S
    Intensive Care Med; 1994; 20(1):47-8. PubMed ID: 8163759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment.
    Asano-Mori Y; Kanda Y; Oshima K; Watanabe T; Shoda E; Motokura T; Kurokawa M; Chiba S
    J Antimicrob Chemother; 2006 May; 57(5):1004-7. PubMed ID: 16551692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.
    Trang JM; Kidd L; Gruber W; Storch G; Demmler G; Jacobs R; Dankner W; Starr S; Pass R; Stagno S
    Clin Pharmacol Ther; 1993 Jan; 53(1):15-21. PubMed ID: 8380762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates.
    Serabe BM; Murry DJ; Dauser R; Nuchtern J; Durfee J; McGuffey L; Berg S; Blaney SM
    Cancer Chemother Pharmacol; 1999; 43(5):415-8. PubMed ID: 10100598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrarenal clearance, distribution volume, and elimination rate of digoxin and metildigoxin in anuric patients.
    Twittenhoff WD; Strauch M; Kütemeyer M; Koch K; Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):405-8. PubMed ID: 7298247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS
    Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of valganciclovir and ganciclovir in renal impairment.
    Czock D; Scholle C; Rasche FM; Schaarschmidt D; Keller F
    Clin Pharmacol Ther; 2002 Aug; 72(2):142-50. PubMed ID: 12189361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic assessment of oral ganciclovir in lung transplant recipients with cystic fibrosis.
    Snell GI; Kotsimbos TC; Levvey BJ; Skiba M; Rutherford DM; Kong DC; Williams TJ; Krum H
    J Antimicrob Chemother; 2000 Apr; 45(4):511-6. PubMed ID: 10747829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and specific liquid-chromatographic assay for determination of ganciclovir in plasma and urine and its application to pharmacokinetic studies in the rabbit.
    Hedaya MA; Sawchuk RJ
    Pharm Res; 1990 Nov; 7(11):1113-8. PubMed ID: 2293208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and clearance of ganciclovir during continuous hemodiafiltration.
    Gando S; Kameue T; Nanzaki S; Hayakawa T; Nakanishi Y
    Crit Care Med; 1998 Jan; 26(1):184-7. PubMed ID: 9428565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function.
    Pescovitz MD; Pruett TL; Gonwa T; Brook B; McGory R; Wicker K; Griffy K; Robinson CA; Jung D
    Transplantation; 1998 Oct; 66(8):1104-7. PubMed ID: 9808499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of famotidine by haemodialysis in elderly anuric patients.
    Inotsume N; Nishimura M; Nakano M; Fujiyama S; Sagara K; Sato T; Matsushita K; Imai Y; Matsui H
    Eur J Clin Pharmacol; 1990; 38(3):313-4. PubMed ID: 2340853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function.
    Sommadossi JP; Bevan R; Ling T; Lee F; Mastre B; Chaplin MD; Nerenberg C; Koretz S; Buhles WC
    Rev Infect Dis; 1988; 10 Suppl 3():S507-14. PubMed ID: 2847287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin.
    Davies BE; Boon R; Horton R; Reubi FC; Descoeudres CE
    Br J Clin Pharmacol; 1988 Oct; 26(4):385-90. PubMed ID: 3190988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of cytomegalovirus infections with ganciclovir in kidney transplant recipients. Clinical and pharmacokinetic study].
    Rondeau E; Farquet C; Fries D; Sraer JD
    Presse Med; 1991 Nov; 20(40):2030-2. PubMed ID: 1662377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.
    Sunzel M; Learoyd M; Li J; Li Y; Ngo N; Edeki T
    Int J Antimicrob Agents; 2015 Dec; 46(6):682-8. PubMed ID: 26545441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
    Perrottet N; Robatel C; Meylan P; Pascual M; Venetz JP; Aubert JD; Berger MM; Decosterd LA; Buclin T
    J Antimicrob Chemother; 2008 Jun; 61(6):1332-5. PubMed ID: 18344549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.